POS0317 WORLD MORTALITY OF SPONDYLOARTHRITIS AND INFLAMMATORY BOWEL DISEASES IN 2015 AND ITS EVOLUTION BETWEEN 2001 AND 2015

• Published in: Annals of the Rheumatic Diseases
• Main Authors: Fakih, O., Prati, C., Wendling, D., Verhoeven, F.
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMJ 2022
• Subjects: General Biochemistry, Genetics and Molecular Biology; Immunology; Immunology and Allergy; Rheumatology; Iceland
• Online Access: http://dx.doi.org/10.1136/annrheumdis-2022-eular.1802; https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.1802

Background There is little epidemiological data on mortality in spondyloarthritis (SpA). Objectives To determine countries’ mortality rates of ankylosing spondylitis (AS) and psoriatic arthritis (PsA), as well as chronic inflammatory bowel diseases (IBDs), which are physiologically related to SpA, and to describe their evolution between 2001 and 2015. Methods We used mortality data from the World Health Organisation (WHO), freely available on its website, which shows the number of deaths classified by age, sex, and cause of death coded by ICD-10. The code M45 was used for AS, L405 for PsA, K50 for Crohn’s disease (CD), and K51 for ulcerative colitis (UC). Age-standardized mortality rates (ASMR) were constructed using the 2015 WHO reference population and are expressed as deaths per million inhabitants. Temporal trend analyses of ASMR were performed between 2001 and 2015, considering only countries with up to 3 years of missing data, using joinpoint regression. Results In 2015, the global ASMR of AS was 0.13 (0.11-0.14), ranging from 0.02 in Japan to 2.00 in Iceland (Figure 1A). The ASMR was 0.20 (0.18-0.23) for men and 0.07 (0.06-0.09) for women (p<0.0001). The trend analysis did not show any significant variation between 2001 and 2015. The ASMR in Europe (0.17 (0.15-0.20)) was significantly higher than in North America (0.12 (0.09-0.14)) (p=0.008), South America (0.09 (0.06-0.12)) (p=0.0001) and Asia (0.08 (0.05-0.10)) (p<0.0001). Figure 1. 2015 ASMR by country for ankylosing spondylitis (A), psoriatic arthritis (B), Crohn’s disease (C) and ulcerative colitis (D). For PsA, the global ASMR in 2015 was 0.04 (0.03-0.05), ranging from 0.01 in Mexico to 0.13 in Greece (Figure 1B). The ASMR was 0.06 (0.04-0.07) for men and 0.03 (0.02-0.04) for women (p=0.01). The trend analysis showed a significant increase from 2004 to 2015 with a mean annual percent change (APC) of 5.94% (p=0.02). The ASMR in Europe (0.05 (0.03-0.06)) was significantly higher than in South America (0.02 (0.00-0.03)) (p=0.02). For CD, the ...